The difficult—and often delayed—diagnosis of CTCL

See allHide authors and affiliations

Science Translational Medicine  07 Oct 2015:
Vol. 7, Issue 308, pp. 308fs41
DOI: 10.1126/scitranslmed.aad2518

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


High-throughput sequencing of T cell receptors to define and quantify T cell populations emerges as a diagnostic tool with the remarkable ability to discriminate between CTCL and benign inflammatory conditions (Kirsch et al., this issue).

View Full Text

Stay Connected to Science Translational Medicine

Editor's Blog